Home > Boards > US OTC > Cannabis >

Wuhan General Group Inc. ( MJ MedTech) (WUHN)

Add WUHN Price Alert      Hide Sticky   Hide Intro
Moderator: relativity
Search This Board: 
Last Post: 1/15/2019 5:17:21 AM - Followers: 57 - Board type: Free - Posts Today: 0

OLD Profile

Sector: Industrials
Industry: Heavy Electrical Equipment
Wuhan General Group (China) Co., Ltd. is a China-based holding company. The Company operates through its subsidiaries, Wuhan Blower Co., Ltd., which is engaged in energy generation in the field; Wuhan Generating Equipment Co., Ltd.; Wuhan Xin Green Environmental Protection Equipment Manufacturing Co., Ltd., which is focused on numerical control machine tools, fans and power plant auxiliary products in the field of manufacturing. The Company, through its subsidiaries, also manufactures fans and power generation equipment, and power plant auxiliary products. The Company is also a supplier of CNC machine tool equipment. Its focus is on equipment manufacturing, environmental protection and new energy fields.

New Company

In 2017, New Management took control of the shell and spent money and effort during 2018 to clean up the shell.
  • They have settled and paid off all past debts with the State of Nevada and the Transfer Agent.
    They brought the company back to Pink current status and plan to up list to OTCQB
    Also, they have renewed OTCIQ service and Nevada State licence for a full year.
    They have reduced the outstanding common shares count to 39.7M shares from 100M.
    No toxic notes have been issued and management have been following their promises.
    Changed SIC - Industry Classification to 2833 - Medicinal and botanicals
    Company website: https://wuhn.org/
New Management

Ramy Kamaneh
Interim CEO, President

Dr. Anna Morera Leralta

Jeff Robison (on the right)
New upcoming CEO
Note that he is having breakfast with Matthew Bucklin ( on the left), husband of Ariana Rockefeller.
How Rich Is the Rockefeller Family Today? The value of Rockefeller's fortune at its peak, in today's dollars, at $318.3 billion in Sep 1, 2016

New Profile
Wuhan General Group is an alternative medicinal and botanicals company focused on the application of emerging technologies as well as the clinical research and health application of cannabidiol (CBD)-based medicine to the human and pet care industry for cancer, cardiovascular, mental disorders, chronic pain, and others in Canada, the United States, Europe, and Australia. We are committed to supplying medical grade CBD products, superior patient care while increasing shareholders ROI. We're on track to achieve a positive cash flow in the first quarter of 2019. According to a new estimate from cannabis industry analysts the Brightfield Group, the CBD market alone could hit $22 billion by 2022.

Press Release | 12/19/2018
Wuhan Provides Update on Its Entry into The Cannabis Market
Press Release | 11/19/2018
Wuhan Provides MJ MedTech Acquisition Update
Press Release | 10/09/2018
Medical Marijuana Company Acquisition: Wuhan Strengthens International Entry in the Marijuana Market
Press Release | 10/04/2018
ePlay and Wuhan Announce Strategic Partnership to Create New Medical Cannabis App
Press Release | 10/04/2018
Wuhan Signs Letter of Intent to Acquire MJ MedTech
Press Release | 09/18/2018
Wuhan Announces Appointment of Chief Medical Officer
Press Release | 09/14/2018
Wuhan General Group confirms the cancelation of 60% of its outstanding common shares
Coming Acquisitions